Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. 1994

F A van den Brûle, and A Berchuck, and R C Bast, and F T Liu, and C Gillet, and M E Sobel, and V Castronovo
Metastasis Research Laboratory, University of Liège, Belgium.

The expression of the 67-kD laminin receptor (67LR) and the 31-kD human laminin-binding protein (HLBP31), two proteins involved in cancer cell laminin interaction, was evaluated on 30 ovarian cancer specimens. Expression of the 67LR was increased (up to 2.5-fold, in 87% of the patients), while HLBP31 expression was downregulated in cancer cells compared with the normal tissue, as detected by northern blotting and immunohistochemistry. The immunohistochemical study demonstrated that the 67LR was significantly overexpressed (P < 0.05) in the group of patients whose cytoreductive surgery was suboptimal, and those with poor clinical outcome. No correlation was observed between HLBP31 expression and clinicopathological features. Increased expression of the 67LR appears to correlate with the invasive phenotype of ovarian cancer cells and suggests a role of the latter in ovarian cancer invasion.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007797 Laminin Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion. Merosin,Glycoprotein GP-2,Laminin M,Laminin M Chain,Chain, Laminin M,Glycoprotein GP 2,M Chain, Laminin
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017474 Receptors, Laminin Glycoprotein molecules on the surface of cells that react with or bind to laminin whose function allows the binding of epithelial cells to the basement membrane. The molecular weight of this high-affinity receptor is 67 kD. Laminin Receptors,Laminin Receptor,Receptor, Laminin

Related Publications

F A van den Brûle, and A Berchuck, and R C Bast, and F T Liu, and C Gillet, and M E Sobel, and V Castronovo
March 1999, Human pathology,
F A van den Brûle, and A Berchuck, and R C Bast, and F T Liu, and C Gillet, and M E Sobel, and V Castronovo
August 1996, European journal of cancer (Oxford, England : 1990),
F A van den Brûle, and A Berchuck, and R C Bast, and F T Liu, and C Gillet, and M E Sobel, and V Castronovo
May 1997, The Journal of pathology,
F A van den Brûle, and A Berchuck, and R C Bast, and F T Liu, and C Gillet, and M E Sobel, and V Castronovo
February 1996, Journal of cellular biochemistry,
F A van den Brûle, and A Berchuck, and R C Bast, and F T Liu, and C Gillet, and M E Sobel, and V Castronovo
March 1993, Journal of the National Cancer Institute,
F A van den Brûle, and A Berchuck, and R C Bast, and F T Liu, and C Gillet, and M E Sobel, and V Castronovo
July 1994, Cell adhesion and communication,
F A van den Brûle, and A Berchuck, and R C Bast, and F T Liu, and C Gillet, and M E Sobel, and V Castronovo
January 1992, Anticancer research,
F A van den Brûle, and A Berchuck, and R C Bast, and F T Liu, and C Gillet, and M E Sobel, and V Castronovo
October 1993, Seminars in cancer biology,
F A van den Brûle, and A Berchuck, and R C Bast, and F T Liu, and C Gillet, and M E Sobel, and V Castronovo
August 1997, Journal of the National Cancer Institute,
F A van den Brûle, and A Berchuck, and R C Bast, and F T Liu, and C Gillet, and M E Sobel, and V Castronovo
July 2000, The Journal of pathology,
Copied contents to your clipboard!